Sonography could replace biopsy in some breast tumors

Article

Ultrasound is an acceptable alternative to biopsy for the management of tumors hidden to x-ray mammography but diagnosed as probably benign under the ultrasound Breast Imaging Reporting and Data System, according to a study in the July issue of Radiology.

Ultrasound is an acceptable alternative to biopsy for the management of tumors hidden to x-ray mammography but diagnosed as probably benign under the ultrasound Breast Imaging Reporting and Data System, according to a study in the July issue of Radiology.

Investigators at the Ambulatory Care Center in Steyr, Austria, retrospectively evaluated 445 nonpalpable solid masses from 409 women who underwent ultrasound between January 2001 and December 2003. These masses were partially or completely obscured by dense breast tissue on mammography but were classified as probably benign by ultrasound. Of the 445 masses, 442 remained stable during a mean follow-up of more than three years. The false-negative rate and negative predictive value of the test were 0.2% and 99.8%, respectively.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.